Recordati Industria Chimica E Farmaceutica S.P.A. (OTCMKTS:RCDTF – Get Free Report) saw a large drop in short interest in July. As of July 15th, there was short interest totaling 129,033 shares, a drop of 32.8% from the June 30th total of 191,938 shares. Based on an average daily trading volume, of 32 shares, the days-to-cover ratio is currently 4,032.3 days. Approximately 0.1% of the company’s shares are sold short.
Recordati Industria Chimica E Farmaceutica Stock Performance
RCDTF stock remained flat at $58.00 during mid-day trading on Friday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.86. The company has a market capitalization of $11.97 billion, a P/E ratio of 20.68 and a beta of 0.25. The business’s fifty day moving average is $58.70 and its 200 day moving average is $59.35. Recordati Industria Chimica E Farmaceutica has a 12-month low of $55.88 and a 12-month high of $60.00.
Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last issued its earnings results on Wednesday, July 29th. The company reported $0.91 EPS for the quarter. Recordati Industria Chimica E Farmaceutica had a net margin of 18.38% and a return on equity of 34.46%. The business had revenue of $810.70 million for the quarter.
About Recordati Industria Chimica E Farmaceutica
Recordati Industria Chimica e Farmaceutica is an Italy‐based international pharmaceutical company engaged in the research, development, manufacturing and commercialization of therapeutic products. Established in 1926, the company has built a diversified portfolio that includes proprietary drugs, generics and orphan medicines, with a particular emphasis on treatments for rare diseases. Recordati’s product range spans cardiovascular, urology, endocrinology, dermatology and oncology therapies, as well as specialized formulations for genetic and metabolic disorders.
The company’s historical roots date back nearly a century, when it began as a family‐owned enterprise in Milan.
See Also
- Five stocks we like better than Recordati Industria Chimica E Farmaceutica
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Recordati Industria Chimica E Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica E Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
